Application Situation of Chinese Medicine Injections in the First Affiliated Hospital of Henan University of Chinese Medicine from 2019 to 2023

ZHU Xiaoli; ZHOU Xiaoli; WANG Kuipeng; WANG Panpan

doi:10.3969/j.issn.1004-437X.2025.04.002

Abstract：Objective To analyze the use and changing trends of Chinese medicine injections in the First Affiliated Hospital of Henan University of Chinese Medicine,and to provide reference for rational clinical use and drug management.Methods Retrospective analysis of medication data for Chinese medicine injections in hospital from 2019 to 2023,including drug indicators such as sales amount,medication frequency,daily average cost,and ranking ratio(B/A).Results The sales amount of Chinese medicine injections in the First Affiliated Hospital of Henan University of Chinese Medicine showed an overall increasing trend from 2019 to 2023,but the proportion in the total sales amount of Chinese patent medicines decreased year by year,and the decline was significant in 2022 due to the public health event.The top five in sales amount within five years were blood stasis-removing agents,anti-tumor drugs,heat-clearing agents,tonifying agents,and dampness-removing agents.The defined daily dose frequency and daily drug cost(DDC)of Shuxuening injection and Salvianolate for injection of blood stasis-removing agents,and Tanreqing injection of heat-clearing agents were in the top 10 for five consecutive years.The B/A of Xueshuantong injection(lyophilized)and Salvianolate for injection was greater than 1.00.Conclusion By analyzing the use of Chinese medicine injections in the First Affiliated Hospital of Henan University of Chinese Medicine from 2019 to 2023,it is found that the use of Chinese medicine injections is basically reasonable,and some irrational use phenomena have been greatly improved after the intervention of relevant measures,but individual drugs still need to be strengthened management.